Preferred Name | CYLD mediated deubiquitination of RIG-I | |
Synonyms |
|
|
Definitions |
Reviewed: Kawai, T, Akira, S, 2010-10-30 CYLD is an ovarian tumor (OTU) domain-containing deubiquitinating enzyme (DUB) and has been identified as a negative regulator of RIG-I mediated antiviral signaling. CYLD associates with the CARD domain of RIG-I and removes K63-linked ubiquitin from the RIG-I CARDs that are conjugated by the E3 ubiquitin ligase, TRIM25 and RNF135. Authored: Garapati, P V, 2010-08-02 Edited: Garapati, P V, 2010-08-22 |
|
ID |
http://purl.obolibrary.org/obo/HINO_0007910 |
|
comment |
Reviewed: Kawai, T, Akira, S, 2010-10-30 CYLD is an ovarian tumor (OTU) domain-containing deubiquitinating enzyme (DUB) and has been identified as a negative regulator of RIG-I mediated antiviral signaling. CYLD associates with the CARD domain of RIG-I and removes K63-linked ubiquitin from the RIG-I CARDs that are conjugated by the E3 ubiquitin ligase, TRIM25 and RNF135. Authored: Garapati, P V, 2010-08-02 Edited: Garapati, P V, 2010-08-22 |
|
definition source |
Pubmed18467330 Pubmed18636086 Reactome, http://www.reactome.org |
|
has input | ||
has output | ||
label |
CYLD mediated deubiquitination of RIG-I |
|
prefixIRI |
HINO:0007910 |
|
prefLabel |
CYLD mediated deubiquitination of RIG-I |
|
seeAlso |
Reactome Database ID Release 43936390 ReactomeREACT_25235 |
|
subClassOf |